Meglucon Xr

Metformin Hydrochloride, the active ingredient in Meglucon Xr, is a biguanide presented as an oral tablet for oral use. It reduces hepatic glucose production and enhances peripheral insulin sensitivity, helping to control blood sugar in adults with type 2 diabetes mellitus.

GNH USA supplies Meglucon Xr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing EU‑sourced medication that meets stringent quality standards and regulatory compliance across global markets.

Meglucon Xr (metformin) is employed in the management of disorders related to impaired glucose regulation.

Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose. Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when combined with lifestyle measures. Polycystic ovary syndrome (PCOS): reduces insulin resistance and may help restore ovulatory function.

Metformin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea or upset stomach - Diarrhea - Metallic taste in the mouth - Abdominal discomfort or cramping - Decreased appetite

Serious or Rare Side Effects: - Lactic acidosis, a potentially life‑threatening condition - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic dysfunction or failure - Significant vitamin B12 deficiency with long‑term use - Acute pancreatitis

When prescribing Meglucon Xr, several safety considerations should be observed.

Renal function: assess creatinine clearance before initiating therapy and periodically thereafter. Hepatic function: evaluate liver enzymes as impaired function increases risk of lactic acidosis. Lactic acidosis risk: avoid in patients with conditions predisposing to hypoxia such as severe heart failure. Vitamin B12 status: monitor for deficiency with long‑term use. Alcohol consumption: limit intake to reduce lactic acidosis risk. Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Metformin interacts with several medicines that may alter its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents used in imaging studies - Cimetidine, a histamine H2‑receptor antagonist - Excessive alcohol intake leading to hypoxia

Moderate Interactions (Monitor Closely): - Beta‑blockers, which may mask hypoglycaemia symptoms - Diuretics, potentially affecting renal clearance of metformin - ACE inhibitors or ARBs, requiring renal function monitoring - Warfarin, may require INR monitoring due to altered anticoagulant effect